FTC concerns with "overbroad" patents should be communicated to policy makers -- staff report.
Executive Summary
FTC CONCERNS WITH "OVERBROAD" PATENT PROTECTION should be communicated to Congress, the Patent & Trademark Office, the courts and the Registrar of Copyrights, a Federal Trade Commission staff report on "Competition Policy in the New High-Tech, Global Marketplace" states. "FTC should continue to articulate to intellectual property policy makers the potential competitive consequences of overbroad patent rights and their aggressive enforcement," the report states. "Such a preventive approach is likely to reduce the number of instances in which antitrust enforcers are confronted with the complex task of parsing procompetitive and anticompetitive effects of business conduct involving intellectual property."
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth